Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

3.6%

2 terminated/withdrawn out of 56 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

4%

2 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

30 recruiting

Enrollment Performance

Analytics

N/A
8(44.4%)
Phase 2
8(44.4%)
Phase 3
2(11.1%)
18Total
N/A(8)
Phase 2(8)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (56)

Showing 20 of 56 trials
NCT07551453Completed

The Return-to-Work Experience of Cancer Patients: A Descriptive Phenomenological Study

Role: lead

NCT07539038Recruiting

Effects of Physical Activity in Early Stage Hormone Receptor Positive Breast Cancer Patients

Role: lead

NCT07527416Recruiting

Textual Analysis of Narratives Produced by Adolescent Oncology Patients: A Research Project

Role: lead

NCT07517458Recruiting

The Assessment of Preoperative Anxiety in Cancer Patients: Validation, Observational, Descriptive Study.

Role: lead

NCT06822959Active Not Recruiting

The INTEGRATE Study: Integrated Pharmacogenetics, TDM and Active Pharmacovigilance as Innovative Tools for the Optimisation and Appropriateness of Drug Therapy

Role: collaborator

NCT07433777Recruiting

Reference Intervals With Indirect Methods in Italy

Role: lead

NCT07397624Recruiting

Endoscopic Suture Gastroplasty (ESG) for Treatment of Obese Patients With Endometrial Cancer

Role: lead

NCT07374731Recruiting

Identification of Biomarkers of Risk for Pre-neoplastic and Neoplastic Lesions for the Development of Gastric Cancer

Role: lead

NCT07344363Recruiting

Prostate Cancer REsearch Using Cross-validation of Innovative Sampling, Integrating LC-MS/MS for Optimized Therapeutic Drug moNitoring

Role: lead

NCT06917469Completed

Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO

Role: lead

NCT06830356Not ApplicableRecruiting

Somatostatin Receptor PET Imaging to Guide Radiotherapy Dose Escalation in High Risk Meningiomas.

Role: lead

NCT06805812Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

Role: collaborator

NCT06738459Recruiting

Precision Retrospective Integrative Study for Metastatic Lymph Nodes in Breast Cancer

Role: lead

NCT06718530Recruiting

Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Cancer Development

Role: lead

NCT06668818Recruiting

Clinical Nursing Practice Supported by Results of Research: Mixed-method Study

Role: lead

NCT06639178Not ApplicableRecruiting

Effectiveness of an N-acetylcysteine and Urea-based Cream in Prevention of Capecitabine-induced HAND-foot Syndrome in Breast Cancer Patients

Role: lead

NCT04172220Not ApplicableCompleted

Does Type of Anesthesia Influence Inflammation Change After Breast Surgery?

Role: lead

NCT06639165Recruiting

Retrospective-perspective Observational Cohort Study on Toxicity and Efficacy of Radiotherapy in Pediatric and Adult Patients With Pediatric Histology Treated at the Pediatric Radiotherapy of the CRO in Aviano

Role: lead

NCT06637345Recruiting

Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO)

Role: lead

NCT06620055Recruiting

Development of an Artificial Intelligence Model for Optimising Therapy in Gliomas Gliomas

Role: lead